Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,673
Total Claims
$465K
Drug Cost
997
Beneficiaries
$467
Cost/Patient
Risk Score Breakdown 29/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+114%
Opioid rate vs peers
88.5% vs 41.3% avg
+17%
Cost per patient vs peers
$467 vs $399 avg
+106%
Brand preference vs peers
7.7% vs 3.8% avg
Opioid Prescribing
88.5%
Opioid Rate
5,019
Opioid Claims
$433K
Opioid Cost
16.7%
Long-Acting Rate
This provider's opioid prescribing rate of 88.5% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 438 claims · $255K
Generic: 5,235 claims · $210K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 132 | $94K |
| Oxycodone Myristate | 120 | $81K |
| Oxycodone Hcl/Acetaminophen | 2,279 | $66K |
| Buprenorphine | 115 | $44K |
| Oxycodone Hcl/Acetaminophen | 11 | $44K |
| Hydrocodone/Acetaminophen | 1,351 | $33K |
| Oxycodone Hcl | 42 | $32K |
| Naloxone Hcl | 91 | $7,297 |
| Oxycodone Hcl | 390 | $6,962 |
| Morphine Sulfate | 268 | $6,366 |
| Pregabalin | 99 | $4,516 |
| Fentanyl | 59 | $3,542 |
| Gabapentin | 159 | $2,517 |
| Morphine Sulfate | 90 | $1,877 |
| Methadone Hcl | 89 | $1,315 |
Prescribing Profile
20
Unique Drugs
29.0
Anomaly Score
Patient Profile
68
Avg Age
62%
Female
1.48
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About